In Patients with Symptomatic Carotid Artery Stenosis Is Endarterectomy Safer Than Carotid Stenting?

2017 ◽  
pp. 321-329
Author(s):  
Benjamin Colvard ◽  
Wei Zhou
Keyword(s):  
Carotid Artery ◽  
Carotid Artery Stenosis ◽  
Carotid Stenting ◽  
Artery Stenosis ◽  
Symptomatic Carotid

scholarly journals Factors associated with time delay to carotid stenting in patients with a symptomatic carotid artery stenosis

2011 ◽  
Vol 258 (7) ◽  
pp. 1228-1233 ◽  
Author(s):  
Klaus Gröschel ◽  
Sonja Schnaudigel ◽  
Katrin Wasser ◽  
Sara M. Pilgram-Pastor ◽  
Ulrike Ernemann ◽  
...  
Keyword(s):  
Time Delay ◽  
Carotid Artery ◽  
Carotid Artery Stenosis ◽  
Carotid Stenting ◽  
Artery Stenosis ◽  
Symptomatic Carotid ◽  
Factors Associated

In-Hospital Outcomes of Urgent, Early, or Late Revascularization for Symptomatic Carotid Artery Stenosis

Stroke ◽  
2021 ◽  
Author(s):  
Christina L. Cui ◽  
Hanaa Dakour-Aridi ◽  
Jinny J. Lu ◽  
Kevin S. Yei ◽  
Marc L. Schermerhorn ◽  
...  
Keyword(s):  
Carotid Artery ◽  
Carotid Artery Stenosis ◽  
Carotid Stenting ◽  
Artery Stenosis ◽  
Optimal Timing ◽  
Hospital Outcomes ◽  
Carotid Revascularization ◽  
Symptomatic Carotid ◽  
Revascularization Procedures ◽  
Stroke Death

Background and Purpose: Advancements in carotid revascularization have produced promising outcomes in patients with symptomatic carotid artery stenosis. However, the optimal timing of revascularization procedures after symptomatic presentation remains unclear. The purpose of this study is to compare in-hospital outcomes of transcarotid artery revascularization (TCAR), transfemoral carotid stenting (TFCAS), or carotid endarterectomy (CEA) performed within different time intervals after most recent symptoms. Methods: This is a retrospective cohort study of United States patients in the vascular quality initiative. All carotid revascularizations performed for symptomatic carotid artery stenosis between September 2016 and November 2019 were included. Procedures were categorized as urgent (0–2 days after most recent symptom), early (3–14 days), or late (15–180 days). The primary outcome of interest was in-hospital stroke and death. Secondary outcomes include in-hospital stroke, death, and transient ischemic attacks. Multivariable logistic regression was used to compare outcomes. Results: A total of 18 643 revascularizations were included: 2006 (10.8%) urgent, 7423 (39.8%) early, and 9214 (49.42%) late. Patients with TFCAS had the highest rates of stroke/death at all timing cohorts (urgent: 4.0% CEA, 6.9% TFCAS, 6.5% TCAR, P =0.018; early: 2.5% CEA, 3.8% TFCAS, 2.9% TCAR, P =0.054; late: 1.6% CEA, 2.8% TFCAS, 2.3% TCAR, P =0.003). TFCAS also had increased odds of in-hospital stroke/death compared with CEA in all 3 groups (urgent adjusted odds ratio [aOR], 1.7 [95% CI, 1.0–2.9] P =0.03; early aOR, 1.6 [95% CI, 1.1–2.4] P =0.01; and late aOR, 1.9 [95% CI, 1.2–3.0] P =0.01). TCAR and CEA had comparable odds of in-hospital stroke/death in all 3 groups (urgent aOR, 1.9 [95% CI, 0.9–4], P =0.10), (early aOR, 1.1 [95% CI, 0.7–1.7], P =0.66), (late aOR, 1.5 [95% CI, 0.9–2.3], P =0.08). Conclusions: CEA remains the safest method of revascularization within the urgent period. Among revascularization performed outside of the 48 hours, TCAR and CEA have comparable outcomes.

Mycophenolate mofetil attenuates plaque inflammation in patients with symptomatic carotid artery stenosis

2010 ◽  
Vol 211 (1) ◽  
pp. 231-236 ◽  
Author(s):  
Sander I. van Leuven ◽  
Diederik F. van Wijk ◽  
Oscar L. Volger ◽  
Jean-Paul P.M. de Vries ◽  
Chris M. van der Loos ◽  
...  
Keyword(s):  
Mycophenolate Mofetil ◽  
Carotid Artery ◽  
Carotid Artery Stenosis ◽  
Artery Stenosis ◽  
Symptomatic Carotid ◽  
Plaque Inflammation

Abstract 2509: Standardized Reports Are Needed To Describe Carotid Artery Stenosis

Stroke ◽  
2012 ◽  
Vol 43 (suppl_1) ◽  
Author(s):  
Eric Cheng ◽  
Salomeh Keyhani ◽  
Susan Ofner ◽  
Linda Williams ◽  
Dawn Bravata
Keyword(s):  
Decision Making ◽  
Clinical Trials ◽  
Carotid Artery ◽  
Carotid Artery Stenosis ◽  
Diagnostic Tests ◽  
Artery Stenosis ◽  
Fiscal Year ◽  
Symptomatic Carotid ◽  
Imaging Results ◽  
Exact Degree

Background: Landmark clinical trials have shown that carotid procedures can greatly reduce the risk of stroke in persons with symptomatic carotid artery stenosis between 70 and 99% and can somewhat reduce the risk of stroke in persons with symptomatic carotid stenosis between 50 and 69%. Guidelines have recommended that results from carotid artery imaging tests be presented in these ranges to facilitate decision-making. We sought to determine how carotid imaging results were reported across Veterans Administration (VA) facilities. Methods: Carotid artery imaging results were obtained as part of a comprehensive chart review of veterans hospitalized with ischemic stroke at 127 VA hospitals in fiscal year 2007. Abstractors recorded the results of carotid ultrasound, MR angiography, CT angiography, or catheter angiography performed in the twelve months prior to admission to six months after admission. We excluded carotid artery imaging reports with results of “no stenosis”, “mild stenosis”, exact degree of stenosis <50%, or any range of stenosis <50% to focus on those reports that would likely inform decisions about carotid procedures. The unit of analysis was the carotid artery. We described how often the results were presented as an exact degree (such as 60%), as a range (such as 50 to 69%), or as a descriptive category (“moderate” or “severe” stenosis). For results described as a range, we examined how often it matched those used in landmark trials. Results: Of 6527 results of carotid artery imaging, there were 1315 results of greater than 50% or at least “moderate stenosis” (see Table ). Only 234 of the reports used a range to describe the stenosis; among this set, only 55 of the reports used a 50-69% or 70-99% range to describe the stenosis. Conclusions: In this national healthcare system, significant carotid artery stenosis was rarely reported in a way that exactly mapped onto recommendations from landmark clinical trials and guidelines. Clinicians who order these diagnostic tests as well as clinicians who interpret these diagnostic tests should collaborate to produce standardized reports that facilitate decision-making.

Sign in / Sign up

Export Citation Format

Share Document